| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |